Advantage Solutions Reports First Quarter 2025 Results — Neutral

ADV   GlobeNewsWire — May 12, 2025

Supporting clients through a challenging operating environment Continuing to make progress on transformation initiatives that will streamline operations Management lowers guidance to reflect heightened market uncertainty ST. LOUIS, May 12, 2025 (GLOBE NEWSWIRE) -- Advantage Solutions Inc. (NASDAQ: ADV) (“Advantage,” “Advantage Solutions,” the “Company,” “we,” or “our”), a leading business solutions provider to consumer goods manufacturers and retailers, today reported financial results for the three months ended March 31, 2025.

image for news Advantage Solutions Reports First Quarter 2025 Results

Harvard Bioscience Announces First Quarter 2025 Financial Results — Neutral

HBIO   GlobeNewsWire — May 12, 2025

HOLLISTON, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the first quarter ended March 31, 2025.

image for news Harvard Bioscience Announces First Quarter 2025 Financial Results

TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Sprott Inc. (NYSE/TSX: SII) (“Sprott”) on behalf of the Sprott Physical Uranium Trust (TSX: U.UN) (TSX: U.U) (“SPUT” or the “Trust”) today announced that SPUT has completed a US$25.55 million non-brokered private placement of trust units. The proceeds are expected to be used to cover general operating expenses of the Trust for the next year.

image for news Sprott Physical Uranium Trust Raises US$25.55 Million Through Non-Brokered Private Placement

United Healthcare approves claim for PoNS Device at out-of-network adjusted list price, becoming the second payer to join Anthem in providing PoNS reimbursement United Healthcare approves claim for PoNS Device at out-of-network adjusted list price, becoming the second payer to join Anthem in providing PoNS reimbursement

image for news Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device

Tiziana Life Sciences Announces Purchase of Shares by Chairman — Neutral

TLSA   GlobeNewsWire — May 12, 2025

NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human anti-CD3 monoclonal antibody, today announces that its Executive Chairman and Founder, Mr.

image for news Tiziana Life Sciences Announces Purchase of Shares by Chairman

Leading American manufacturer builds on longstanding commitment to creating jobs and driving economic prosperity through expanded investment in its breweries, technical skills training, and support for hiring veterans ST. LOUIS , May 12, 2025 /PRNewswire/ -- Today, Anheuser-Busch (NYSE: BUD), a leading American manufacturer and maker of Michelob ULTRA, Busch Light, Budweiser and Bud Light, proudly expanded its commitment to creating and sustaining U.S. manufacturing jobs by announcing it will invest $300 million in its facilities across the United States.

image for news ANHEUSER-BUSCH ANNOUNCES NEW $300 MILLION INVESTMENT IN MANUFACTURING OPERATIONS ACROSS THE U.S.

Navigation database developed by Garmin will bring more cost-effective options for customers in theregion OLATHE, Kan. , May 12, 2025 /PRNewswire/ -- Garmin (NYSE: GRMN) today announced expanded coverage of the Garmin Navigation Database to include the South Pacific region, including Australia, New Zealand and surrounding countries.

image for news Garmin expands avionics database solutions for South Pacific region

Invesco Ltd. Announces April 30, 2025 Assets Under Management — Neutral

IVZ   PRNewsWire — May 12, 2025

ATLANTA , May 12, 2025 /PRNewswire/ -- Invesco Ltd. (NYSE: IVZ)1 today reported preliminary month-end assets under management (AUM) of $1,840.0 billion, a decrease of 0.3% versus previous month-end.

image for news Invesco Ltd. Announces April 30, 2025 Assets Under Management

SOUTH SAN FRANCISCO, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (NASDAQ:CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today announced the pricing of an underwritten offering of 76,923,076 shares of its common stock at an offering price of $1.30 per share, before underwriting discounts and commissions. All of the shares are being offered by the Company. The gross proceeds from the offering are expected to be approximately $100 million before deducting underwriting discounts and commissions and other offering expenses. The offering is expected to close on May 13, 2025, subject to customary closing …

image for news CytomX Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock

Expansion of potential treatment applications of deucrictibant in people living with bradykinin-mediated angioedema Expansion of potential treatment applications of deucrictibant in people living with bradykinin-mediated angioedema

image for news Pharvaris to Host a Virtual R&D Call “Deucrictibant: Beyond HAE Type 1/2” on June 4

US Dollar Forecast: Bullish Outlook After 90-Day U.S.-China Tariff Pause — Positive

AAAU  DGL  DGP  GLD  GLDM  IAU  IAUF  OUNZ  UGL   FXEmpire — May 12, 2025

DXY rallies as U.S.-China tariff truce boosts risk appetite. Traders eye 50-day moving average resistance at 102.10 and CPI data for confirmation of further upside momentum.

image for news US Dollar Forecast: Bullish Outlook After 90-Day U.S.-China Tariff Pause

Lazard Reports April 2025 Assets Under Management — Neutral

LAZ   Business Wire — May 12, 2025

NEW YORK--(BUSINESS WIRE)--Lazard, Inc. (NYSE: LAZ) reported today that its preliminary assets under management (“AUM”) as of April 30, 2025 totaled approximately $231.4 billion. The month's AUM included FX appreciation of $5.1 billion, market depreciation of $0.9 billion, and net outflows of $0.2 billion. LAZARD, INC. ASSETS UNDER MANAGEMENT (“AUM”) (unaudited) ($ in millions) As of: April 30, March 31, 20251 2025 Equity $176,313 $174,130 Fixed Income 46,341 44,024 Other 8,754 9,.

image for news Lazard Reports April 2025 Assets Under Management

Sally Beauty Holdings Reports Second Quarter Fiscal 2025 Results — Neutral

SBH   Business Wire — May 12, 2025

DENTON, Texas--(BUSINESS WIRE)--Sally Beauty Holdings, Inc. (NYSE: SBH) (“the Company”), the leader in professional hair color, today announced financial results for its second quarter ended March 31, 2025. The Company will hold a conference call today at 7:30 a.m. Central Time to discuss these results and its business. Fiscal 2025 Second Quarter Summary Consolidated net sales of $883 million, a decrease of 2.8% compared to the prior year, includes 110 basis points of unfavorable foreign curren.

image for news Sally Beauty Holdings Reports Second Quarter Fiscal 2025 Results

Somnigroup Announces Launch of Secondary Offering of Common Stock — Neutral

SGI   PRNewsWire — May 12, 2025

DALLAS , May 12, 2025 /PRNewswire/ -- Somnigroup International Inc. (NYSE: SGI, "Company" or "Somnigroup") today announced the launch of a secondary offering (the "Offering") of 15,376,743 shares of its common stock, par value $0.01 per share, by the former majority shareholder of Mattress Firm Group Inc., which shareholder is a subsidiary of IBEX Topco B.V. (the "Selling Stockholder").

image for news Somnigroup Announces Launch of Secondary Offering of Common Stock

Fortrea Reports First Quarter 2025 Results — Neutral

FTRE   GlobeNewsWire — May 12, 2025

For the three months ended March 31, 2025, from continuing operations: Revenues of $651.3 million GAAP net loss of $(562.9) million, inclusive of a non-cash goodwill impairment charge Adjusted EBITDA of $30.3 million GAAP and adjusted net (loss) income per diluted share of $(6.25) and $0.02, respectively Book-to-bill ratio of 1.02x, resulting in 1.14x book-to-bill for the trailing 12 months DURHAM, N.C., May 12, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today reported financial results for the first quarter ended March 31, 2025.

image for news Fortrea Reports First Quarter 2025 Results

IBIT: Bitcoin Might Be Entering The Parabolic Phase — Positive

IBIT   Seeking Alpha — May 12, 2025

Bitcoin's current cycle suggests a potential parabolic phase, with previous cycles indicating a rally until about October 2025. Technical indicators like RSI and MACD on Bitcoin's weekly chart signal a new bullish uptrend, reinforcing the breakout from a bull flag formation. Trade deals and potential Federal Reserve rate cuts could act as catalysts, boosting Bitcoin's price and equities by increasing liquidity and reducing market uncertainties.

image for news IBIT: Bitcoin Might Be Entering The Parabolic Phase

Is this the best-timed Tesla stock insider trade of 2025? — Positive

TSLA   Finbold — May 12, 2025

Director Joseph Gebbia's April 24 insider trade of Tesla (NASDAQ: TSLA) stock was immediately noted as unusual for being the first of its kind in years, and, by May 12, 2025, it also proved highly lucrative.

image for news Is this the best-timed Tesla stock insider trade of 2025?

Petrobras Declares High-Quality Oil Discovery in Brazil's Santos Basin — Positive

PBR   Zacks Investment Research — May 12, 2025

PBR discovers high-quality oil in the Santos Basin's Aram block, bolstering Brazil's pre-salt exploration momentum.

image for news Petrobras Declares High-Quality Oil Discovery in Brazil's Santos Basin

New Strong Sell Stocks for May 12th — Negative

CAL  E  PMTS   Zacks Investment Research — May 12, 2025

E, CAL and PMTS have been added to the Zacks Rank #5 (Strong Sell) List on May 12, 2025.

image for news New Strong Sell Stocks for May 12th

Cheniere Energy Q1 Earnings Miss Estimates, Revenues Rise Y/Y — Negative

LNG   Zacks Investment Research — May 12, 2025

LNG's Q1 earnings miss estimates due to higher operating costs and expenses. Revenues hit $5.4B and guidance for 2025 remains strong.

image for news Cheniere Energy Q1 Earnings Miss Estimates, Revenues Rise Y/Y